A University of Pittsburgh faculty member since 1987, Dr. Kormos is internationally regarded for his clinical and research work in the use of cardiac assist devices as temporary or permanent support for patients with end-stage heart disease as well as cardiac transplantation. He has authored more than 250 published articles and book chapters on these subjects. In a new venture, he is directing a consortium of UPMC clinicians and engineers from Carnegie Mellon University and the University of Pittsburgh to develop advanced biosensors for medical applications.
Dr. Kormos has been the recipient of numerous awards, including the Transplant Recipients International Organization (TRIO) Award, Annual Celebration of Life Award, the Pittsburgh Business Times Health Care Hero Award, and the Carnegie Science Center Awards for Excellence, Chairman’s Award. He has been listed in America’s Top Doctors, Castle Connolly Medical Ltd., from 2001-09, as well as being listed in Pittsburgh’s Top Doctors, Castle Connolly Medical Ltd., consistently from 2005 to present.
Dr. Kormos completed fellowships in research and transplant surgery at the University of Pittsburgh. He also completed internships and residencies in neurosurgery, and cardiovascular and thoracic surgery at Toronto General Hospital. A native of Canada, Dr. Kormos received his medical degree from the University of Western Ontario in London, Ontario.
Dr. Kormos is an associate editor for The Journal of Heart and Lung Transplantation and is a member of more than 17 professional societies. He is a past president of the International Society for Heart and Lung Transplantation and has served on the board of the American Society for Transplant Surgery. Dr. Kormos was interim medical director of the mechanical circulatory support registry of the United Network for Organ Sharing and International Society for Heart and Lung Transplantation, and is a member of the Education Task Force for the Society of Thoracic Surgeons. Dr. Kormos is co-principle investigator of the National Heart, Lung and Blood Institute(NHLBI)-sponsored Interagency Registry for Mechanical Circulatory Support (INTERMACS), which contains information on nearly 2,000 approved assist devices used as bridge to transplantation, recovery and destination therapy. He also serves as chair of the NHLBI’s Adverse Events Subcommittee and has succeeded in establishing a set of definitions now adopted by the FDA and industry and clinical investigators worldwide.